About Galenica
Galenica is a company based in Geneve (Switzerland) founded in 1927. It operates as a Managed Services. The company has 6,120 employees as of December 31, 2024. Galenica has completed 8 acquisitions, including Aquantic, Aspreva Pharmaceutics and BMC SSI. Galenica offers products and services including Integrated Healthcare Solutions.
- Headquarter Geneve, Switzerland
- Employees 6120 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Galenica Ag
-
Annual Revenue
$4.33 B (USD)4.67as on Dec 31, 2024
-
Net Profit
$201.94 M (USD)5.39as on Dec 31, 2024
-
EBITDA
$343.51 M (USD)7.95as on Dec 31, 2024
-
Latest Funding Round
$735.54 M (USD), Post-IPO
Mar 18, 2015
- Investors
-
Employee Count
6120
as on Dec 31, 2024
-
Investments & Acquisitions
Aquantic
& 7 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Galenica
Galenica is a publicly listed company on the SIX with ticker symbol GALE in Switzerland, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Galenica
Galenica offers a comprehensive portfolio of products and services, including Integrated Healthcare Solutions.
Healthcare needs are met with personalized, efficient solutions.
People of Galenica
Unlock access to complete
Unlock access to complete
Software Development Team
41 people
Human Resources and Administration
16 people
Leadership Team
10 people
Sales and Marketing
10 people
Head Team
5 people
Finance and Accounting
5 people
Data Analysis and Operations Team
5 people
Lead Team
5 people
Unlock access to complete
Funding Insights of Galenica
Investors in Galenica
Galenica has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Alliance Boots.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Chain of pharmacies
|
Locked | Locked | Locked |
Investor details for Galenica
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Galenica
Galenica has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Aquantic, Aspreva Pharmaceutics and BMC SSI.
Investment portfolio details for Galenica
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Digital solutions for in-patient care management are provided.
|
Locked | Locked | 2014 | Locked | |
|
Non-absorbed polymeric drugs for cardiovascular and renal diseases are developed.
|
Locked | Locked | 2007 | Locked | |
|
Medicines for rare autoimmune disorders were developed by Aspreva Pharmaceutics.
|
Locked | Locked | 2001 | Locked |
Complete acquisition details for Galenica
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Galenica
Detailed financials for Galenica
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Galenica Comparisons
Peer comparison for Galenica
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Galenica
Detailed competitors of Galenica
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Galenica
Complete news archive for Galenica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Galenica
Galenica was founded in 1927 and raised its 1st funding round 72 years after it was founded.
Galenica is headquartered in Geneve, Switzerland. It is registered at Geneve, Geneve, Switzerland.
As of Dec 31, 2024, the latest employee count at Galenica is 6,120.
Annual revenue of Galenica is $4.33B as on Dec 31, 2024.
Galenica is established as a leader in the Swiss healthcare market through its extensive network of over 20 Business Units. Healthcare needs of patients and customers are addressed in a seamless, efficient, and personalized manner. The strongest partnerships in the Swiss healthcare sector are maintained to shape the future of healthcare. Significant growth in sales and profitability is achieved, as reported in the first half of 2025.
Galenica offers Integrated Healthcare Solutions.
Yes, Galenica is publicly traded on SIX under the ticker symbol GALE.
Galenica has made 8 acquisitions, including Aquantic, Aspreva Pharmaceutics, and BMC SSI.
Galenica has 1 investor. Key investors include Alliance Boots.
The ticker symbol of Galenica is GALE on SIX.